Samsung and Apollo Hospitals Launch Mobile Clinic to fight NCDs

S Singh
S Singh
· 3 min read
NCD
Detection of NCD risk factors requires simple, reliable, safe, and low-cost approaches

Samsung India Electronics and Apollo Hospitals Group launched the ‘Samsung-Apollo Mobile Clinic’ to provide access to quality, preventive healthcare against growing non-communicable diseases (NCDs) to the less privileged. With this program, the two organisations aim to leverage technology to ensure citizens in rural areas in need of healthcare have access to it.

The Samsung-Apollo Mobile Medical Care Unit Program was inaugurated by Hon’ble Governor of Tamil Nadu, Shri. Banwarilal Purohit in the presence of Dr. Prathap C Reddy, Chairman of Apollo Hospitals Group, Ms Sangita Reddy, Joint Managing Director, Apollo Hospitals and Mr. Jae Young Yang, Managing Director, Samsung Manufacturing Plant .

Samsung-Apollo Mobile Clinic is well equipped with high-end technology, for advance screening facilities of NCDs (non-communicable diseases). NCDs are a growing menace across the world. Responsible for over 50% of deaths, NCDs like Diabetes, Cancer, Hypertension & Cardiac ailments cause biggest fatalities in India. Samsung Apollo Mobile Clinic is targeted to win over NCDs by driving awareness and conducting early detection and preventive screening.

People at the rural areas will receive free-of-cost access to primary screening. Medical professionals from Apollo Hospitals will be engaged to execute the primary requirement of screening and camps through this initiative. Encouraging this initiative Hon’ble Governor of Tamil Nadu, Shri Banwarilal Purohit, said: “It is a commendable partnership between Samsung and Apollo Hospital and I appreciate their endeavour towards serving India and making it healthier. Together, Samsung and Apollo Hospitals will now ensure they will reach citizens by creating access to quality prevention and early detection services right at their doorsteps. Healthcare needs increased focus and I am happy to be part of this journey to make a difference.”

Marking this momentous occasion, Dr. Prathap C Reddy, Executive Chairman, Apollo Hospitals Group, said: “The biggest challenge in India is to make Healthcare facilities accessible to one and all, especially in the wake of the rising incidences of NCDs. An estimated 17 million people die of cardiovascular diseases worldwide every year. The solution to all this is early detection and prevention. But in our vast country, everyone cannot access hospitals due to time & distance issues. Apollo Hospitals decided to take the accessibility challenge head on. Powered by Samsung, we now have a Mobile  Clinic, which will reach everyone who needs health care. We are starting this with Tamil Nadu and will soon spread this across other States as well. Our fight with NCDs is not limited to Metros, so why must our healthcare be limited to hospitals. Apollo Hospitals will reach every citizen and ensure we all stay healthy. Only healthy and happy citizens can build a prosperous India. And at Apollo we are doing our bit to ensure this.”

“Samsung believes in transforming communities and creating a better life for people. We are pleased to partner with Apollo Hospitals for the Samsung-Apollo Mobile Clinic that will provide free medical screening camps and primary healthcare services for non-communicable diseases to the less-privileged in Tamil Nadu. Through this collaboration, we aspire to bridge the gap and provide access to quality healthcare facilities to the people of the state,” said Mr. Peter Rhee, Corporate Vice President, Samsung India Electronics.

Read Next

MedGenome makes a majority investment in Siddhi Diagnostics & Research Centre  
News
May 20, 2026

MedGenome makes a majority investment in Siddhi Diagnostics & Research Centre  

MedGenome has joined hands with Siddhi Diagnostics & Research Centre (SDRC), a well-established diagnostic imaging service provider with a strong presence across Mumbai’s extended western suburbs. Founded in 1995, SDRC is led by Dr. Ajit Pungavkar and Dr. Sona Pungavkar. Dr. Ajit, a renowned sonologist with over 35 years of clinical experience, has devoted his […]
Article by: IMT News Desk
Lupin Receives Tentative Approval from U.S. FDA for Revefenacin Inhalation Solution
News
May 20, 2026

Lupin Receives Tentative Approval from U.S. FDA for Revefenacin Inhalation Solution

Global pharma major, Lupin Limited (Lupin), has announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Revefenacin Inhalation Solution, 175 mcg/3 mL Unit-Dose Vials. Lupin’s Revefenacin Inhalation Solution, 175 mcg/3 mL is bioequivalent to Mylan’s Yupelri® Inhalation Solution and indicated for […]
Article by: IMT News Desk
HCG opens new 132‑bed Bengaluru oncology facility with ₹129 crore investment
News
May 20, 2026

HCG opens new 132‑bed Bengaluru oncology facility with ₹129 crore investment

HealthCare Global Enterprises (HCG) has inaugurated a new 132‑bed comprehensive cancer care hospital in Hebbal/North Bengaluru, marking its third oncology facility in the city and expanding its network across Karnataka and India. Scale and investment The new Bengaluru facility represents a total investment of approximately ₹129 crore, funded through a mix of debt and internal […]
Article by: IMT News Desk
Hidden sugar patterns on the cell surface could enable early cancer detection, a new study shows
News
May 20, 2026

Hidden sugar patterns on the cell surface could enable early cancer detection, a new study shows

Scientists have uncovered a hidden “sugar code” on the surface of human cells that could revolutionize early‑stage cancer diagnosis, according to a new study published in Nature Nanotechnology by researchers at the Max Planck Institute for the Science of Light (MPL). What the study found Every human cell is coated with a thin layer of sugar molecules […]
Article by: IMT News Desk